A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community Pharmacies
Launched by UNIVERSITY OF ALBERTA · Jul 15, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Please see the following publication for a detailed description of the work:
Pilot and Feasibility Studies 01/2015; 1(2). DOI: 10.1186/2055-5784-1-2
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pharmacies: Community pharmacy locations of a medium-sized pharmacy chain with an interest in and the ability to provide medication management services, but have not fully integrated these activities
- • Patients: Any Alberta residents qualifying for pharmacy clinical services as defined by the Alberta Pharmacy Fee Framework
- Exclusion Criteria:
- • None
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Ross T Tsuyuki, PharmD, MSc
Principal Investigator
University of Alberta
Meagen M Rosenthal, BA, MA, PhD
Study Director
University of Alberta
Sherilyn KD Houle, BSP, PhD
Study Director
University of Waterloo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials